1. Xu, Yating, Xia, Di, Huang, Kai, Liang, Minglu. 2024. Hypoxia-induced P4HA1 overexpression promotes post-ischemic angiogenesis by enhancing endothelial glycolysis through downregulating FBP1. In Journal of translational medicine, 22, 74. doi:10.1186/s12967-024-04872-x. https://pubmed.ncbi.nlm.nih.gov/38238754/
2. Cao, Jiali, Zhong, Qiangqiang, Huang, Yumei, Wang, Ziwen, Xiong, Zhifan. 2023. Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease. In Biochemical and biophysical research communications, 686, 149180. doi:10.1016/j.bbrc.2023.149180. https://pubmed.ncbi.nlm.nih.gov/37922570/
3. Zhou, Rui, Qiu, Lin, Zhou, Ling, Yang, Shiping, Wu, Jiangxue. 2023. P4HA1 activates HMGCS1 to promote nasopharyngeal carcinoma ferroptosis resistance and progression. In Cellular signalling, 105, 110609. doi:10.1016/j.cellsig.2023.110609. https://pubmed.ncbi.nlm.nih.gov/36702290/
4. Wu, Changwu, Gong, Siming, Duan, Yingjuan, Osterhoff, Georg, Schopow, Nikolas. 2023. A tumor microenvironment-based prognostic index for osteosarcoma. In Journal of biomedical science, 30, 23. doi:10.1186/s12929-023-00917-3. https://pubmed.ncbi.nlm.nih.gov/37055822/